4.1. Analysis.
Comparison 4: Topotecan versus Topotecan/thalidomide, Outcome 1: Progression free survival
Progression free survival | ||||
Study | Group | Median (month) | 95% CI | P value |
Downs 2008 | Topotecan | 4 | 2.9 to 5.1 | |
Topotecan with thalidomide | 6 | 4.2 to 7.7 | 0.02 |